LC	Lung cancer
NSCLC	Non-small-cell lung cancer
SCLC	Small-cell lung cancer
ICI	Immune checkpoint inhibitor
AGEs	Advanced glycation end products
RAGE	Receptor for advanced glycation end products
sRAGE	Soluble receptor for advanced glycation end products
cRAGE	Cleaved receptor for advanced glycation end products
esRAGE	Endogenous secreted receptor for advanced glycation end products
PD-L1	Programmed death ligand 1
NAFLD	Non-alcoholic fatty liver disease
NASH	Non-alcoholic steatohepatitis
CV	Coefficient of variation
AST	Aspartate Aminotransferase
ALT	Alanine Aminotransferase
RECIST	Response Evaluation Criteria in Solid Tumors
PFS	Progression-free survival
OS	Overall survival
ROC	Receiver operating characteristic
NLR	Neutrophil-to-lymphocyte ratio
PLR	Platelet-to-lymphocyte ratio
ARDS	Acute respiratory distress syndrome
HMGB1	High-Mobility Group Box 1